NO20022645D0 - Farmasöytisk superdisintegrerende stoff - Google Patents

Farmasöytisk superdisintegrerende stoff

Info

Publication number: NO20022645D0
Authority: NO; Norway
Prior art keywords: superdisintegrant; pharmaceutical; pharmaceutical superdisintegrant
Prior art date: 1999-12-06

Application number

NO20022645A

Other languages

English (en)

Other versions

NO20022645L (no

Inventor

John Nicholas Staniforth

Original Assignee

Penwest Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-06

Filing date

2002-06-05

Publication date

2002-06-05

2002-06-05 Application filed by Penwest Pharmaceutical Co filed Critical Penwest Pharmaceutical Co

2002-06-05 Publication of NO20022645D0 publication Critical patent/NO20022645D0/no

2002-08-01 Publication of NO20022645L publication Critical patent/NO20022645L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Medicinal Preparation (AREA)

NO20022645A 1999-12-06 2002-06-05 Farmasöytisk superdisintegrerende stoff NO20022645L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16917499P	1999-12-06	1999-12-06
PCT/US2000/032989 WO2001039746A1 (en)	1999-12-06	2000-12-06	Pharmaceutical superdisintegrant

Publications (2)

Publication Number	Publication Date
NO20022645D0 true NO20022645D0 (no)	2002-06-05
NO20022645L NO20022645L (no)	2002-08-01

Family

ID=22614504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022645A NO20022645L (no)	1999-12-06	2002-06-05	Farmasöytisk superdisintegrerende stoff

Country Status (11)

Country	Link
US (2)	US6660303B2 (no)
EP (1)	EP1244428A1 (no)
KR (1)	KR20020062323A (no)
AU (2)	AU771440B2 (no)
BR (1)	BR0016482A (no)
CA (1)	CA2393231A1 (no)
HU (1)	HUP0301333A3 (no)
IL (1)	IL150053A0 (no)
MX (1)	MXPA02005562A (no)
NO (1)	NO20022645L (no)
WO (1)	WO2001039746A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0204771D0 (en) *	2002-02-28	2002-04-17	Phoqus Ltd	Fast disintegrating tablets
AU2003256284A1 (en) *	2002-06-20	2004-01-06	Orapharma, Inc.	Rapidly disintegrating formulations for treating or preventing mucositis
SI21221A (sl) *	2002-06-21	2003-12-31	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Hitro razpadljive tablete
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
AU2004296877A1 (en) *	2003-12-09	2005-06-23	Incyte Corporation	Dosing methods for ss-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
DE602005008721D1 (de) *	2004-03-10	2008-09-18	Ranbaxy Lab Ltd	Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid
US20050220865A1 (en) *	2004-04-02	2005-10-06	Koleng John J	Compressed composition comprising magnesium salt
JP2007532623A (ja) *	2004-04-12	2007-11-15	ファイザー・プロダクツ・インク	破裂型多重粒子中の味マスキング薬物
ES2550626T5 (es) *	2005-02-25	2019-01-15	Takeda Pharmaceuticals Co	Método para producir gránulos
JP2009501801A (ja) *	2005-07-18	2009-01-22	ホライゾンセラピューティクス，インコーポレイテッド	イブプロフェンとファモチジンとを含有する医薬およびその投与
US20080020040A1 (en) *	2006-07-18	2008-01-24	Horizon Therapeutics, Inc.	Unit dose form for administration of ibuprofen
US8067451B2 (en) *	2006-07-18	2011-11-29	Horizon Pharma Usa, Inc.	Methods and medicaments for administration of ibuprofen
US8067033B2 (en)	2007-11-30	2011-11-29	Horizon Pharma Usa, Inc.	Stable compositions of famotidine and ibuprofen
US11116728B2 (en)	2006-11-30	2021-09-14	Bend Research, Inc.	Multiparticulates of spray-coated drug and polymer on a meltable core
WO2008065504A1 (en) *	2006-11-30	2008-06-05	Pfizer Products Inc.	Multiparticulates of spray-coated drug and polymer on a meltable core
WO2008079343A2 (en) *	2006-12-21	2008-07-03	Mallinckrodt Inc.	Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
ES2758624T3 (es) *	2009-02-12	2020-05-06	Fuji Chem Ind Co Ltd	Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma
WO2010107507A1 (en) *	2009-03-20	2010-09-23	Incube Labs, Llc	Solid drug delivery apparatus, formulations and methods of use
US20100285164A1 (en) *	2009-05-11	2010-11-11	Jrs Pharma	Orally Disintegrating Excipient
US20160008310A1 (en) *	2014-07-11	2016-01-14	Azanta A/S	Misoprostol dispersible tablet
TN2017000003A1 (en) *	2014-07-11	2018-07-04	Azanta Danmark As	Misoprostol dispersible tablet.
EP4110263A4 (en) *	2020-02-27	2024-04-17	Henkel AG & Co. KGaA	PERSONAL CARE PRODUCT AND METHOD FOR PRODUCING A PERSONAL CARE PRODUCT BY A GENERATIVE PROCESS
CN112618503B (zh) *	2021-01-20	2022-04-15	天津市中央药业有限公司	头孢地尼分散片
CN118903036B (zh) *	2024-10-10	2025-03-04	华夏罕见病药物研发(山东)有限公司	一种含尿苷的组合物的制备方法及其在治疗发育性癫痫性脑病50型中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3141875A (en)	1961-03-15	1964-07-21	Fmc Corp	Crystallite aggregates disintegrated in acid medium
GB2042888B (en) *	1979-03-05	1983-09-28	Teijin Ltd	Preparation for administration to the mucosa of the oral or nasal cavity
US4772473A (en) *	1986-06-16	1988-09-20	Norwich Eaton Pharmaceuticals, Inc.	Nitrofurantoin dosage form
US4910023A (en) *	1988-06-09	1990-03-20	Warner-Lambert Company	Drug in combination with flavor masking agent and method for making same
HU203041B (en)	1989-03-14	1991-05-28	Egyt Gyogyszervegyeszeti Gyar	Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
US5468286A (en) *	1989-10-25	1995-11-21	National Starch And Chemical Investment Holding Corporation	Enzymatically debranched starches as tablet excipients
IT1241417B (it) *	1990-03-06	1994-01-14	Vectorpharma Int	Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
CA2041774C (en)	1990-11-27	1994-04-19	Mircea A. Mateescu	Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5215757A (en) *	1991-03-22	1993-06-01	The Procter & Gamble Company	Encapsulated materials
US5272191A (en)	1991-08-21	1993-12-21	Fmc Corporation	Cold water soluble films and film forming compositions
AU668198B2 (en)	1992-07-24	1996-04-26	Labopharm (Barbados) Limited	Cross-linked polyhydroxylic material for enzymatically controlled drug release
US5616343A (en)	1993-03-25	1997-04-01	Labopharm, Inc.	Cross-linked amylose as a binder/disintegrant in tablets
US6106865A (en)	1995-01-09	2000-08-22	Edward Mendell Co., Inc.	Pharmaceutical excipient having improved compressibility
IL116674A (en)	1995-01-09	2003-05-29	Mendell Co Inc Edward	Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5585115A (en)	1995-01-09	1996-12-17	Edward H. Mendell Co., Inc.	Pharmaceutical excipient having improved compressability
US5948438A (en)	1995-01-09	1999-09-07	Edward Mendell Co., Inc.	Pharmaceutical formulations having improved disintegration and/or absorptivity
US5733578A (en)	1995-11-15	1998-03-31	Edward Mendell Co., Inc.	Directly compressible high load acetaminophen formulations
TW430561B (en) *	1995-12-20	2001-04-21	Gea Farmaceutisk Fabrik As	Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
CA2217238C (en)	1997-10-24	2005-09-20	Louis Cartilier	Cross-linked cellulose as a tablet excipient

2000
- 2000-12-06 BR BR0016482-8A patent/BR0016482A/pt not_active Application Discontinuation
- 2000-12-06 CA CA002393231A patent/CA2393231A1/en not_active Abandoned
- 2000-12-06 AU AU20614/01A patent/AU771440B2/en not_active Ceased
- 2000-12-06 HU HU0301333A patent/HUP0301333A3/hu unknown
- 2000-12-06 WO PCT/US2000/032989 patent/WO2001039746A1/en not_active Application Discontinuation
- 2000-12-06 EP EP00983920A patent/EP1244428A1/en not_active Withdrawn
- 2000-12-06 US US09/731,238 patent/US6660303B2/en not_active Expired - Fee Related
- 2000-12-06 MX MXPA02005562A patent/MXPA02005562A/es unknown
- 2000-12-06 KR KR1020027007259A patent/KR20020062323A/ko not_active IP Right Cessation
- 2000-12-06 IL IL15005300A patent/IL150053A0/xx unknown
2002
- 2002-06-05 NO NO20022645A patent/NO20022645L/no not_active Application Discontinuation
2003
- 2003-10-02 US US10/677,847 patent/US20050100600A1/en not_active Abandoned
2004
- 2004-06-10 AU AU2004202515A patent/AU2004202515A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1244428A1 (en)	2002-10-02
AU2004202515A1 (en)	2004-07-01
US20020068084A1 (en)	2002-06-06
AU771440B2 (en)	2004-03-25
US20050100600A1 (en)	2005-05-12
WO2001039746A1 (en)	2001-06-07
KR20020062323A (ko)	2002-07-25
HUP0301333A3 (en)	2005-06-28
CA2393231A1 (en)	2001-06-07
AU2061401A (en)	2001-06-12
IL150053A0 (en)	2002-12-01
BR0016482A (pt)	2002-12-24
MXPA02005562A (es)	2004-09-10
HUP0301333A2 (hu)	2004-05-28
US6660303B2 (en)	2003-12-09
NO20022645L (no)	2002-08-01

Publication	Publication Date	Title
NO20022645L (no)	2002-08-01	Farmasöytisk superdisintegrerende stoff
DK1637127T3 (da)	2014-08-04	Terapeutisk mikroskum
NO20021400D0 (no)	2002-03-20	Terapeutiske konazolinderivater
ATE392890T1 (de)	2008-05-15	Hydrogel-gesteuerte dosierungsform
NO20015175D0 (no)	2001-10-23	Farmasöytisk sammensetning
DE69930152D1 (de)	2006-04-27	Projektor
IT1315260B1 (it)	2003-02-03	Bendaggio gastrico rimovibile
IS2277B (is)	2007-09-15	Meðferðarlegar bíarýl afleiður
NO20011085L (no)	2001-05-03	Tablett med umiddelbar frigivningsvirkning
NO20022692L (no)	2002-08-07	Terapeutiske midler
DE50001455D1 (de)	2003-04-17	Blisterverpackung
NO20005179D0 (no)	2000-10-13	Medikament behandling
NO20022606D0 (no)	2002-05-31	Farmasöytiske kombinasjoner
NO20014926D0 (no)	2001-10-10	Farmasöytiske forbindelser
FR2802423B1 (fr)	2005-03-25	Compositions pharmaceutiques
DE60032510D1 (de)	2007-02-01	Kondom
DE60025760D1 (de)	2006-04-13	Anisotrop-leitender film
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
DK1176982T3 (da)	2004-03-29	Prucaloprid oral opløsning
IS6163A (is)	2001-11-16	Lyfjakomplex
NO20016301D0 (no)	2001-12-21	Terapeutiske midler
DE59905747D1 (de)	2003-07-03	Blisterpackung
ID26141A (id)	2000-11-30	Film rentang poliolefin
DE50007261D1 (de)	2004-09-09	Mehrschichtverbund
UA2855S (uk)	1999-07-19	Таблетка фармацевтична

Legal Events

Date	Code	Title	Description
2005-09-12	FC2A	Withdrawal, rejection or dismissal of laid open patent application